NCT04298931

Brief Summary

It is well known, that patients with circulatory impairment sometimes, but not always, benefit from intravenous fluids. Predicting if a fluid administration will improve circulation is therefore of substantial clinical interest. Ventilator treatment induces cyclic variation in blood pressure due to interaction between the lungs and the heart. This variation is minor, but its amplitude may be used for guiding fluid administration. However, this method of using ventilator-induced variation in blood pressure to predict the effect of fluid administration was developed when different settings for ventilator treatment was recommended, compared with today. With today's recommend ventilator treatment, the method is, unfortunately, less reliable. The investigators will investigate how different ventilator settings influence variation in blood pressure, and the investigators will test if this knowledge allows us to better predict the effect of a fluid administration, by taking the ventilator settings into account.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 6, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

May 15, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 29, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 29, 2021

Completed
Last Updated

July 16, 2021

Status Verified

April 1, 2021

Enrollment Period

1.1 years

First QC Date

March 2, 2020

Last Update Submit

July 15, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • >10% Increase in stroke volume from before to after a fluid bolus. (Fluid responsiveness)

    A patient is considered a fluid responder if they have a \>10% increase in stroke volume (pulse contour analysis by the Edwards EV1000 with a FloTrac sensor). Pre-fluid stroke volume is calculated as the median stroke volume estimate in the two minutes immediately preceding the fluid bolus. Post-fluid stroke volume is calculated as the median stroke volume estimate in the two minutes immediately following the fluid bolus. Change in stroke volume is calculated as: 100% \* (Post-fluid stroke volume - Pre-fluid stroke volume) / Pre-fluid stroke volume

    From two minutes before to two minutes after a fluid administration.

Study Arms (1)

Patients undergoing open abdominal surgery

Other: Series of ventilator settings

Interventions

Before a planned fluid administration, the investigators will apply a series of 10 ventilator settings for 30 seconds each. The settings are the following combinations of respiratory rate (RR) and tidal volume (TV): RR (min\^-1), TV (ml/kg predicted body weight) 31, 6 31, 8 24, 6 24, 8 17, 6 17, 8 10, 4 10, 6 10, 8 10, 10 (the order of the respiratory rates: 17 to 31, will be randomized. 10/min will always be last. Tidal volume is always applied from lowest to highest for each respiratory rate).

Patients undergoing open abdominal surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients at department of abdominal surgery, Aarhus University Hospital, scheduled for open abdominal surgery with planned use of Aarhus University Hospital's goal-directed therapy protocol (hemodynamic monitoring).

You may qualify if:

  • Scheduled open abdominal surgery.
  • Scheduled treatment with Aarhus University Hospital's goal-directed therapy protocol (hemodynamic monitoring).

You may not qualify if:

  • Left ventricular ejection fraction ≤ 40 %
  • Irregular heart rhythm (e.g. atrial fibrillation or frequent ectopic beats)
  • Known right ventricular dysfunction (if reported qualitatively in pre-operative assessment or objectively via Tricuspid Annular Plane Systolic Excursion (TAPSE) \< 17 mm)
  • Pregnancy
  • Prior participation in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aarhus University Hospital

Aarhus N, 8200, Denmark

Location

Related Publications (1)

  • Enevoldsen J, Brandsborg B, Juhl-Olsen P, Rees SE, Thaysen HV, Scheeren TWL, Vistisen ST. The effects of respiratory rate and tidal volume on pulse pressure variation in healthy lungs-a generalized additive model approach may help overcome limitations. J Clin Monit Comput. 2024 Feb;38(1):57-67. doi: 10.1007/s10877-023-01090-6. Epub 2023 Nov 16.

MeSH Terms

Conditions

HypovolemiaEdema

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 2, 2020

First Posted

March 6, 2020

Study Start

May 15, 2020

Primary Completion

June 29, 2021

Study Completion

June 29, 2021

Last Updated

July 16, 2021

Record last verified: 2021-04

Locations